Scarica l'app Stockscreener
17.14
0.61%
-0.105
Pre-mercato:
16.56
-0.58
-3.38%
Precedente Chiudi:
$17.25
Aprire:
$17.28
Volume 24 ore:
159.24K
Relative Volume:
1.02
Capitalizzazione di mercato:
$1.05B
Reddito:
-
Utile/perdita netta:
$-46.13M
Rapporto P/E:
-21.10
EPS:
-0.8123
Flusso di cassa netto:
$-34.10M
1 W Prestazione:
-3.55%
1M Prestazione:
-20.79%
6M Prestazione:
+0.00%
1 anno Prestazione:
+60.49%
Intervallo 1D:
$16.73
$17.66
Intervallo di 1 settimana:
$16.40
$18.57
Portata 52W:
$6.595
$25.00
Pulse Biosciences Inc Stock (PLSE) Company Profile
Nome
Pulse Biosciences Inc
Settore
Industria
Telefono
510-906-4600
Indirizzo
3957 POINT EDEN WAY, HAYWARD, CA
Confronta PLSE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
17.14 | 1.05B | 0 | -46.13M | -34.10M | -0.8123 |
|
ISRG
Intuitive Surgical Inc
|
493.72 | 176.09B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
224.92 | 64.58B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
89.15 | 44.10B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
225.79 | 33.17B | 4.93B | 1.25B | 1.38B | 8.47 |
|
BAX
Baxter International Inc
|
35.85 | 18.30B | 17.28B | 108.00M | 391.00M | 0.20 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-07-27 | Iniziato | Stephens | Overweight |
| 2021-03-11 | Iniziato | Maxim Group | Buy |
| 2021-01-26 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-12 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Pulse Biosciences Inc Borsa (PLSE) Ultime notizie
Oppenheimer & Co. Inc. Acquires New Shares in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025 - Bluefield Daily Telegraph
When Will Pulse Biosciences Report Q4 Earnings? Key Date for nsPFA Technology Leader - StockTitan
Pulse Biosciences, Inc. to Host Earnings Call - ACCESS Newswire
Pulse Biosciences at TD Cowen Conference: nsPFA Technology Focus By Investing.com - Investing.com Canada
New York State Common Retirement Fund Sells 3,600 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
(PLSE) Trading Signals - Stock Traders Daily
Commit To Purchase Pulse Biosciences At $10, Earn 12.9% Annualized Using Options - Nasdaq
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Joplin Globe
Is Pulse Biosciences' Hiring Spree a Signal for Investors? 165,300 New Stock Options Granted - StockTitan
MONDAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm - ACCESS Newswire
Investor Network: Pulse Biosciences, Inc. to Host Earnings Call - ACCESS Newswire
Jon Skinner Hired to Manage Pulse Biosciences Finances - MPO-mag
Pulse Biosciences Releases Nanosecond PFA Catheter Study Results - MPO-mag
Learn to Evaluate (PLSE) using the Charts - Stock Traders Daily
Pulse Biosciences (NASDAQ:PLSE) Trading Down 7.8%Here's Why - MarketBeat
Can Pulse Biosciences' Novel Ablation Technology Disrupt Medical Device Market? Key Presentation Coming - StockTitan
Where are the Opportunities in (PLSE) - Stock Traders Daily
Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 6.6%Here's What Happened - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Hits New 12-Month HighShould You Buy? - MarketBeat
Pulse Biosciences Appoints Jon Skinner as Chief Financial Officer - Defense World
Pulse Biosciences names new CFO, continuing string of C-suite changes - MedTech Dive
Pulse Biosciences names Jon Skinner as new CFO By Investing.com - Investing.com South Africa
Pulse Biosciences names Jon Skinner as new CFO - Investing.com India
Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer - BioSpace
Pulse Biosciences has a new CFO - Mass Device
Pulse Biosciences Strengthens Leadership with New CFO Appointment - TipRanks
Pulse Biosciences Names Jon Skinner CFO -February 04, 2025 at 08:54 am EST - Marketscreener.com
Pulse Biosciences Appoints Jon Skinner As CFO; Stock Up In Pre-market - Nasdaq
Pulse Biosciences Names Jon Skinner Chief Financial Officer - MarketWatch
Healthcare M&A Expert Takes CFO Role at Pulse Biosciences with $5B Growth Vision - StockTitan
Pulse Biosciences (NASDAQ:PLSE) Trading Up 7.6%Time to Buy? - MarketBeat
Griffin Asset Management Inc. Sells 19,902 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - MarketBeat
(PLSE) Technical Pivots with Risk Controls - Stock Traders Daily
Pulse Biosciences’ Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting - BioSpace
Pulse Biosciences reports successful AF treatment in study - MSN
Pulse Biosciences announces presentation of late-breaking data on nsPFA 360-degree cardiac catheter system - Cardiac Rhythm News
Pulse Biosciences (NASDAQ:PLSE) Shares Up 5.2%Here's What Happened - MarketBeat
Pulse Biosciences touts positive results from PFA early feasibility study - Yahoo Finance
Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium - Business Wire
Barclays PLC Grows Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Purchased by Barclays PLC - MarketBeat
Pulse Biosciences Inc Azioni (PLSE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Pulse Biosciences Inc Azioni (PLSE) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| DUGGAN ROBERT W | Director |
Dec 13 '24 |
Buy |
17.18 |
55,256 |
949,298 |
42,328,717 |
| DUGGAN ROBERT W | Director |
Dec 12 '24 |
Buy |
17.13 |
45,404 |
777,771 |
42,273,461 |
| DUGGAN ROBERT W | Director |
Dec 11 '24 |
Buy |
17.35 |
56,054 |
972,344 |
42,228,057 |
| Barrett Burke Thomas | President and CEO |
May 20 '24 |
Buy |
8.56 |
10,000 |
85,600 |
10,000 |
1.07%
2.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):